Abstract
Urinary tract infection, one of the commonest bacterial diseases in children, carries a substantial risk of serious complications. Amongst them, renal scarring and recurrent infections seem to be the most important. In this review, we analyze the pathogenesis of urinary tract infection in order to identify those children who run the highest risk of unfavorable outcome. During infection, multiple bacterial and host factors interact with each other. Bacteria possess specific characteristics involved in the process of adhesion, invasion, survival and host damage during infection. Host factors also substantially participate in the pathogenesis of the disease. According to current knowledge, the specific host response appears to be the main factor predisposing for complications. However, prompt and adequate treatment of acute urinary tract infection remains the most important measure to prevent scarring. Dysfunctional holding and elimination of urine, on the other hand, mainly seem to influence the development of recurrent infection. Despite intensive research for many years, urinary tract infections are still a challenge for patients and health care professionals.
Keywords: UTI, E. coli, renal scarring, recurrent infections
Current Pediatric Reviews
Title: Urinary Tract Infection. Why Do Some Children Get Complications, While Others Dont?
Volume: 3 Issue: 1
Author(s): Milan Chromek and Annelie Brauner
Affiliation:
Keywords: UTI, E. coli, renal scarring, recurrent infections
Abstract: Urinary tract infection, one of the commonest bacterial diseases in children, carries a substantial risk of serious complications. Amongst them, renal scarring and recurrent infections seem to be the most important. In this review, we analyze the pathogenesis of urinary tract infection in order to identify those children who run the highest risk of unfavorable outcome. During infection, multiple bacterial and host factors interact with each other. Bacteria possess specific characteristics involved in the process of adhesion, invasion, survival and host damage during infection. Host factors also substantially participate in the pathogenesis of the disease. According to current knowledge, the specific host response appears to be the main factor predisposing for complications. However, prompt and adequate treatment of acute urinary tract infection remains the most important measure to prevent scarring. Dysfunctional holding and elimination of urine, on the other hand, mainly seem to influence the development of recurrent infection. Despite intensive research for many years, urinary tract infections are still a challenge for patients and health care professionals.
Export Options
About this article
Cite this article as:
Chromek Milan and Brauner Annelie, Urinary Tract Infection. Why Do Some Children Get Complications, While Others Dont?, Current Pediatric Reviews 2007; 3 (1) . https://dx.doi.org/10.2174/157339607779941705
DOI https://dx.doi.org/10.2174/157339607779941705 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biologic Therapy in Psoriasis: Safety Profile
Current Drug Safety Combinatorial Chemistry and Fragment Screening - Two Unlike Siblings?
Current Drug Discovery Technologies Armed Oncolytic Adenoviruses and Polymer-shielded Nanocomplex for Systemic Delivery
Current Cancer Therapy Reviews Prevention of Cardiovascular Diseases with Anti-Inflammatory and Anti- Oxidant Nutraceuticals and Herbal Products: An Overview of Pre-Clinical and Clinical Studies
Recent Patents on Inflammation & Allergy Drug Discovery Synthetic Derivatives of Osthole for the Prevention of Hepatitis
Medicinal Chemistry Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines
Current Pharmacogenomics and Personalized Medicine Studies on Plant-Pathogen Interactions Using Activity-based Proteomics
Current Proteomics Current Molecular Understanding and Future Treatment Strategies for Pathologic Ocular Neovascularization
Current Molecular Medicine The 5-lipoxygenase (5-LOX) Inhibitor Zileuton Reduces Inflammation and Infarct Size with Improvement in Neurological Outcome Following Cerebral Ischemia
Current Neurovascular Research Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease
Current Medicinal Chemistry Novel Antiviral Strategies to Combat Human Arenavirus Infections
Current Molecular Medicine Alginate Based Nanocarriers for Drug Delivery Applications
Current Pharmaceutical Design Antiviral Therapy of Chronic Hepatitis B with Nucleotide Analogs
Anti-Infective Agents in Medicinal Chemistry Cell Surface Nucleolin as a Target for Anti-Cancer Therapies
Recent Patents on Anti-Cancer Drug Discovery Oxidative Stress and Pathophysiology of Ischemic Stroke: Novel Therapeutic Opportunities
CNS & Neurological Disorders - Drug Targets Role of Immune Cells in Diabetic Kidney Disease
Current Gene Therapy Roles of Chemokine CXCL12 and its Receptors in Ischemic Stroke
Current Drug Targets Role of Statins in Peri-Operative Medicine
Current Drug Targets Editorial [Hot Topic: Novel and Emerging Drugs for Leukemias (Guest Editor: Tadeusz Robak)]
Current Cancer Drug Targets Activation and Activators of TRPV1 and Their Pharmaceutical Implication
Current Pharmaceutical Design